AbbVie, J&J to add proprietary data to AI protein model in bid to accelerate drug discovery
Posted:
Life sciences data company Apheris on Thursday announced an effort to boost the capabilities of protein AI models by uniting several pharmaceutical companies’ proprietary data. Apheris’ consortium of pharma companies is partnering with OpenFold3 — Columbia professor Mohammed AlQuraishi’s open-source dupe of AlphaFold3 — to train the model on AbbVie and Johnson & Johnson’s vast stores of structural data. The collaboration will focus on structures relevant to drug discovery, such as small molecule-protein and antibody-antigen interactions.
The NHS faces unprecedented challenges, from patient dissatisfaction and workforce shortages to outdated infrastructure. Change is no longer optional – it is a necessity. AI, particularly generative AI (or even artificial general intelligence (AGI) in the future), presents a powerful opportunity…
A machine learning algorithm developed by Cambridge scientists was able to correctly identify in 97 cases out of 100 whether or not an individual had coeliac disease based on their biopsy, new research has shown.
Read more here.
Attendees
Sponsors and
Exhibitors
AI In Healthcare: A Virtual Course
Contact us